F. Schillo

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

M. Urioste, P. Chanson, M. Blok, 2012, Clinical Cancer Research.

Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma

F. Aubin, C. Borg, F. Cattin, 2018, Investigational New Drugs.

Evaluation of Nurses’ and Patients’ Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study

I. Sobhani, R. Coriat, S. Bisot-Locard, 2020, Advances in Therapy.

Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey.

Jacques Young, J. Bertherat, P. Caron, 2015, The Journal of clinical endocrinology and metabolism.

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

P. Chanson, A. Tabarin, E. Baudin, 2015, European journal of endocrinology.

Screening of Mutations in Genes that Predispose to Hereditary Paragangliomas and Pheochromocytomas

F. Borson‐Chazot, L. Brunaud, A. Calender, 2012, Hormone and Metabolic Research.

Human Cancer Biology MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

M. Urioste, P. Chanson, M. Blok, 2012 .

First prognostic analysis of stage III adrenocartical carcinoma patients after complete resection: a retrospective French Multicentric Study from the INCA-COMETE network

A. Tabarin, E. Baudin, F. Pattou, 2011 .